about
Role of postoperative radiotherapy in resected non-small cell lung cancer: a reassessment based on new dataHypofractionated Radiotherapy as Adjuvant Treatment in Early Breast Cancer. A Review and Meta-Analysis of Randomized Controlled TrialsFocus on treatment complications and optimal management: radiation oncologyExploiting biological and physical determinants of radiotherapy toxicity to individualize treatmentCombining targeted agents and hypo- and hyper-fractionated radiotherapy in NSCLCImproving radiotherapy planning, delivery accuracy, and normal tissue sparing using cutting edge technologiesRadioembolization of hepatic lesions from a radiobiology and dosimetric perspective2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancerProteasome inhibitors block DNA repair and radiosensitize non-small cell lung cancerAvoiding Severe Toxicity From Combined BRAF Inhibitor and Radiation Treatment: Consensus Guidelines from the Eastern Cooperative Oncology Group (ECOG)Optimal design and patient selection for interventional trials using radiogenomic biomarkers: A REQUITE and Radiogenomics consortium statement.Audiovisual biofeedback improves motion prediction accuracy.Is there an impact of heart exposure on the incidence of radiation pneumonitis? Analysis of data from a large clinical cohort.A data-mining framework for large scale analysis of dose-outcome relationships in a database of irradiated head and neck cancer patients.Extracting the normal lung dose-response curve from clinical DVH data: a possible role for low dose hyper-radiosensitivity, increased radioresistance.Multidisciplinary team approach for the management of patients with locally advanced non-small cell lung cancer: searching the evidence to guide the decision.Effect of normal lung definition on lung dosimetry and lung toxicity prediction in radiation therapy treatment planning.Role of adjuvant radiotherapy in completely resected non-small-cell lung cancer.Heart irradiation as a risk factor for radiation pneumonitis.Is it possible for knowledge-based planning to improve intensity modulated radiation therapy plan quality for planners with different planning experiences in left-sided breast cancer patients?Whole breast and regional nodal irradiation in prone versus supine position in left sided breast cancer.Treating lung cancer with dynamic conformal arc therapy: a dosimetric studyLeft-sided whole breast irradiation with hybrid-IMRT and helical tomotherapy dosimetric comparison.Using generalized equivalent uniform dose atlases to combine and analyze prospective dosimetric and radiation pneumonitis data from 2 non-small cell lung cancer dose escalation protocols.Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysisIMRT sparing of normal tissues in locoregional treatment of breast cancer.Effect of deformable registration on the dose calculated in radiation therapy planning CT scans of lung cancer patients.Challenges scoring radiation pneumonitis in patients irradiated for lung cancer.Cardiac and inflammatory biomarkers do not correlate with volume of heart or lung receiving radiation.Validation of an elastic registration technique to estimate anatomical lung modification in non-small-cell lung cancer tomotherapy.The prognostic value of irradiated lung volumes on the prediction of intra-/ post-operative mortality in patients after neoadjuvant radiochemotherapy for esophageal cancer. A retrospective multicenter study.Associations of LIG4 and HSPB1 genetic polymorphisms with risk of radiation-induced lung injury in lung cancer patients treated with radiotherapyAdvantages of CyberKnife for inoperable stage I peripheral non-small-cell lung cancer compared to three-dimensional conformal radiotherapy.Ion therapy within the trimodal management of superior sulcus tumors: the INKA trial.Accelerated radiotherapy and concurrent chemotherapy for patients with contralateral central or mediastinal lung cancer relapse after pneumonectomyNondosimetric risk factors for radiation-induced lung toxicity.Motion mitigation for lung cancer patients treated with active scanning proton therapyTBI lung dose comparisons using bilateral and anteroposterior delivery techniques and tissue density corrections.Audiovisual biofeedback breathing guidance for lung cancer patients receiving radiotherapy: a multi-institutional phase II randomised clinical trial.Comparison of doses and NTCP to risk organs with enhanced inspiration gating and free breathing for left-sided breast cancer radiotherapy using the AAA algorithm
P2860
Q24633254-0BCAA37A-C356-4276-9343-BA292192F1D2Q26776288-5DA35293-C61B-4BC2-AB61-ED97167D7475Q26824398-42CAFDB1-E995-4C39-84F7-865C5792B5AFQ26849735-6E41DD9D-DA32-45E0-ABDC-B40B10EB0A12Q26852202-A54770EC-488A-4237-8D5D-FFC0EEF4D9B5Q26852685-C5B7E6E2-620F-41D9-9993-F5837A8292C0Q26998661-A1E6E1BB-B1D6-44BA-A2B2-32C95CAB3678Q27002509-9742CAD6-84F9-4575-B588-C5463664DE7DQ27307731-5B478A58-0BAA-47A3-98C1-B2EDAC5E2011Q28079359-B2F37CD9-BFB3-4B45-942D-0BB1EC3F85B8Q30240052-1008CA85-C8CE-4290-979C-04F72B91119CQ30440917-F5F6AB6A-FC34-42CC-878C-930DD3D36E46Q30664267-7A16700A-D73A-43D9-872A-20B327365D2AQ30978160-387DECE2-7DEE-4D5D-BB01-E25981617386Q30988682-1FDB3492-B573-4ABC-B0A1-3E35DF1900DAQ33583931-CB0DAFD8-1367-4E97-981A-13DA828BC314Q33637920-13800225-6D8D-4265-8402-516F4E276FB2Q33698439-E730595D-3CC9-4324-8B6D-CD4B91A29C7FQ33698930-CE8CEB70-134B-45C3-A867-BCC13E676691Q33717005-1FF47BCB-948A-46D3-BAB7-26CD9FD93067Q33733680-947B872B-B23B-4BDB-A310-E46D66E8F8E4Q33759703-D9F4E30C-FA0C-4E3F-A8B8-DDBC87A488BDQ34003177-C23DC2F7-6A3D-4509-9CE8-F3A09266DA98Q34258742-3217B549-15E8-495D-B432-91B4763852E6Q34298368-BB3E7E8A-EEE5-412C-8545-04E348DEFF11Q34470038-9F706403-A3B9-4C8B-B436-3C835F6B5EE7Q34807636-32553383-59EB-45C6-9C3B-C553577F361CQ34872854-9BA2FAF8-C168-4090-9D7A-FA4549DE4B87Q34941764-FCCB61F2-FA2C-4CCD-8631-152E01CE47ACQ34980794-96BFE836-5FB1-4177-8D83-4B97EC751C3FQ35051265-78C9364C-6D7E-469D-8FFB-7686E60BEB01Q35165394-92880444-AB7F-4E30-9D1E-568535A93BC8Q35180015-4695E538-4AA4-4244-BC08-2003E1FA4A0CQ35237816-285AE34F-ECBC-4838-95EC-2FA57C36D47BQ35290831-F2C71626-83E4-4C46-8229-5EC6793AFDC8Q35456001-719A686B-60FB-4EBB-9395-74D2C5EDFEECQ35537591-232C1493-5E1E-4A7B-83E5-22B1961A2484Q35671999-7A233E54-6969-4951-AED3-433A9819CDF7Q35695850-330115DB-9F82-4F7C-8097-BE40FBD13EEEQ35733998-0E4CB723-FA03-4E7B-9E81-A9DDBD0DB158
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Radiation dose-volume effects in the lung.
@en
Radiation dose-volume effects in the lung.
@nl
type
label
Radiation dose-volume effects in the lung.
@en
Radiation dose-volume effects in the lung.
@nl
prefLabel
Radiation dose-volume effects in the lung.
@en
Radiation dose-volume effects in the lung.
@nl
P2093
P2860
P50
P1476
Radiation dose-volume effects in the lung
@en
P2093
Andrew Jackson
Feng-Ming Spring Kong
Jeffrey D Bradley
Jessica L Hubbs
Joos V Lebesque
Lawrence B Marks
Mary K Martel
Robert D Timmerman
P2860
P356
10.1016/J.IJROBP.2009.06.091
P407
P433
P577
2010-03-01T00:00:00Z